Literature DB >> 23062904

Vitamin D in cutaneous carcinogenesis: part II.

Jean Y Tang1, Teresa Fu, Christopher Lau, Dennis H Oh, Daniel D Bikle, Maryam M Asgari.   

Abstract

The role of vitamin D in health maintenance and disease prevention in fields ranging from bone metabolism to cancer is currently under intensive investigation. A number of epidemiologic studies have suggested that vitamin D may have a protective effect on cancer risk and cancer-associated mortality. With regard to skin cancer, epidemiologic and laboratory studies suggest that vitamin D and its metabolites may have a similar risk reducing effect. Potential mechanisms of action include inhibition of the hedgehog signaling pathway and upregulation of nucleotide excision repair enzymes. The key factor complicating the association between vitamin D and skin cancer is ultraviolet B radiation. The same spectrum of ultraviolet B radiation that catalyzes the production of vitamin D in the skin also causes DNA damage that can lead to epidermal malignancies. Part II of this continuing medical education article will summarize the literature on vitamin D and skin cancer to identify evidence-based optimal serum levels of vitamin D and to recommend ways of achieving those levels while minimizing the risk of skin cancer.
Copyright © 2012 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23062904      PMCID: PMC3706259          DOI: 10.1016/j.jaad.2012.07.022

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  81 in total

Review 1.  Novel Hedgehog pathway targets against basal cell carcinoma.

Authors:  Jean Y Tang; Po-Lin So; Ervin H Epstein
Journal:  Toxicol Appl Pharmacol       Date:  2006-12-21       Impact factor: 4.219

2.  Evaluation of ergocalciferol or cholecalciferol dosing, 1,600 IU daily or 50,000 IU monthly in older adults.

Authors:  N Binkley; D Gemar; J Engelke; R Gangnon; R Ramamurthy; D Krueger; M K Drezner
Journal:  J Clin Endocrinol Metab       Date:  2011-02-02       Impact factor: 5.958

3.  In vitro comparison of the vitamin D endocrine system in 1,25(OH)2D3-responsive and -resistant melanoma cells.

Authors:  Jörg Reichrath; Martin Rech; Maryam Moeini; Eckart Meese; Wolfgang Tilgen; Markus Seifert
Journal:  Cancer Biol Ther       Date:  2007-01       Impact factor: 4.742

4.  Diet and risk of cutaneous malignant melanoma: a prospective study of 50,757 Norwegian men and women.

Authors:  M B Veierød; D S Thelle; P Laake
Journal:  Int J Cancer       Date:  1997-05-16       Impact factor: 7.396

5.  Expression profiling of vitamin D treated primary human keratinocytes.

Authors:  Pamela Renate Moll; Veronika Sander; Anna-Maria Frischauf; Klaus Richter
Journal:  J Cell Biochem       Date:  2007-02-15       Impact factor: 4.429

6.  Antitumor effects of two less-calcemic vitamin D analogs (Paricalcitol and QW-1624F2-2) in squamous cell carcinoma cells.

Authors:  Adebusola A Alagbala; Candace S Johnson; Donald L Trump; Gary H Posner; Barbara A Foster
Journal:  Oncology       Date:  2007-01-18       Impact factor: 2.935

7.  1 alpha, 25-Dihydroxyvitamin D3 inhibits phorbol ester-dependent chemical carcinogenesis in mouse skin.

Authors:  A W Wood; R L Chang; M T Huang; M Uskokovic; A H Conney
Journal:  Biochem Biophys Res Commun       Date:  1983-10-31       Impact factor: 3.575

8.  1,25-Dihydroxyvitamin D and three low-calcemic analogs decrease UV-induced DNA damage via the rapid response pathway.

Authors:  G Wong; R Gupta; K M Dixon; S S Deo; S M Choong; G M Halliday; J E Bishop; S Ishizuka; A W Norman; G H Posner; R S Mason
Journal:  J Steroid Biochem Mol Biol       Date:  2004-05       Impact factor: 4.292

9.  The photoprotective effect of 1,25-dihydroxyvitamin D3 on ultraviolet light B-induced damage in keratinocyte and its mechanism of action.

Authors:  J Lee; J I Youn
Journal:  J Dermatol Sci       Date:  1998-09       Impact factor: 4.563

10.  Effectiveness of 1alpha-hydroxyvitamin D2 in inhibiting tumor growth in a murine transgenic pigmented ocular tumor model.

Authors:  Daniel M Albert; Amit Kumar; Stephen A Strugnell; Soesiawati R Darjatmoko; Janice M Lokken; Mary J Lindstrom; Christine M Damico; Sarit Patel
Journal:  Arch Ophthalmol       Date:  2004-09
View more
  18 in total

1.  High prevalence of vitamin D deficiency in patients with xeroderma pigmetosum-A under strict sun protection.

Authors:  A Kuwabara; N Tsugawa; K Tanaka; Y Uejima; J Ogawa; N Otao; N Yamada; T Masaki; C Nishigori; S Moriwaki; T Okano
Journal:  Eur J Clin Nutr       Date:  2015-02-11       Impact factor: 4.016

Review 2.  Vitamin D and Other Differentiation-promoting Agents as Neoadjuvants for Photodynamic Therapy of Cancer.

Authors:  Edward V Maytin; Tayyaba Hasan
Journal:  Photochem Photobiol       Date:  2020-04-15       Impact factor: 3.421

3.  Disturbed expression of vitamin D and retinoic acid-related orphan receptors α and γ and of megalin in inflammatory skin diseases.

Authors:  Anna A Brożyna; Michał A Żmijewski; Kinga Linowiecka; Tae-Kang Kim; Radomir M Slominski; Andrzej T Slominski
Journal:  Exp Dermatol       Date:  2022-01-13       Impact factor: 4.511

Review 4.  The role of vitamin D in reducing cancer risk and progression.

Authors:  David Feldman; Aruna V Krishnan; Srilatha Swami; Edward Giovannucci; Brian J Feldman
Journal:  Nat Rev Cancer       Date:  2014-04-04       Impact factor: 60.716

Review 5.  Vitamin D and Vitamin D Analogs as Adjuncts to Field Therapy Treatments for Actinic Keratoses: Current Research and Future Approaches.

Authors:  Zafer Sattouf; Steven J Repas; Jeffrey B Travers; Craig A Rohan
Journal:  J Skin Cancer       Date:  2021-06-19

Review 6.  Genetic and environmental factors underlying keratinocyte carcinoma risk.

Authors:  Hélène Choquet; Sepideh Ashrafzadeh; Yuhree Kim; Maryam M Asgari; Eric Jorgenson
Journal:  JCI Insight       Date:  2020-05-21

7.  Serum level of vitamin D3 in cutaneous melanoma.

Authors:  Renato Santos de Oliveira Filho; Daniel Arcuschin de Oliveira; Vitor Augusto Melão Martinho; Célia Beatriz Gianotti Antoneli; Ludmilla Altino de Lima Marcussi; Carlos Eduardo dos Santos Ferreira
Journal:  Einstein (Sao Paulo)       Date:  2014 Oct-Dec

Review 8.  Melanoma risk perception and prevention behavior among African-Americans: the minority melanoma paradox.

Authors:  Alina Goldenberg; Igor Vujic; Martina Sanlorenzo; Susana Ortiz-Urda
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-08-05

Review 9.  The relevance of the vitamin D endocrine system (VDES) for tumorigenesis, prevention, and treatment of non-melanoma skin cancer (NMSC): Present concepts and future perspectives.

Authors:  Jörg Reichrath; Sandra Reichrath
Journal:  Dermatoendocrinol       Date:  2013-01-01

Review 10.  Tumor suppression in skin and other tissues via cross-talk between vitamin D- and p53-signaling.

Authors:  Jörg Reichrath; Sandra Reichrath; Kristina Heyne; Thomas Vogt; Klaus Roemer
Journal:  Front Physiol       Date:  2014-06-03       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.